Name | vascular endothelial growth factor B |
Description | This gene encodes a member of the PDGF (platelet-derived growth factor)/VEGF (vascular endothelial growth factor) family. The VEGF family members regulate the formation of blood vessels and are involved in endothelial cell physiology. This member is a ligand for VEGFR-1 (vascular endothelial growth factor receptor 1) and NRP-1 (neuropilin-1). Studies in mice showed that this gene was co-expressed with nuclear-encoded mitochondrial genes and the encoded protein specifically controlled endothelial uptake of fatty acids. Alternatively spliced transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, Sep 2011] |
Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nVEGF‐B is an enigmatic member of the vascular endothelial growth factor family that exists in multiple isoforms and engages primarily with VEGF receptor‐1 and the neuropilin‐1 coreceptor. Structural studies have revealed that VEGF‐B adopts a cysteine‐knot motif that, although similar to that of VEGF‐A and placental growth factor, displays unique receptor‐binding determinants that likely contribute to its tissue‐selective actions. Notably, VEGF‐B is expressed in peripheral tissues such as the skin—where fibroblasts produce detectable levels with distinct regulatory patterns—further supporting its context‐dependent roles. Its endogenous function in pathological angiogenesis, however, remains ambiguous."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "6"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn cardiovascular and metabolic contexts, experimental models have illuminated critical roles for VEGF‐B in modulating lipid metabolism and tissue remodeling. Cardiac‐specific overexpression of VEGF‐B in mice has been shown to induce concentric myocardial hypertrophy accompanied by distinct shifts in lipid profiles and mitochondrial integrity, while elevated VEGF‐B in diabetic kidney disease models correlates with renal lipotoxicity and insulin resistance. Moreover, clinical investigations have linked circulating VEGF‐B levels to dyslipidemia and target‐organ damage, underscoring its potential as a therapeutic target in metabolic disorders and cardiovascular injury."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "7", "end_ref": "12"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the realm of tumor biology and inflammatory regulation, VEGF‐B exhibits a multifaceted, context‐dependent influence on neovascularization and cancer progression. Its expression—detected in immune cells such as basophils—suggests that VEGF‐B may contribute to inflammatory processes. In several malignancies, including hepatocellular, colorectal, and gastric cancers, aberrant or co‐expressed VEGF‐B with its receptors has been associated with enhanced angiogenic signaling, increased extracellular protease activity, and ultimately greater invasive behavior and metastatic potential. Intriguingly, under conditions characterized by high FGF2/FGFR1 expression, VEGF‐B has been reported to act as an endogenous inhibitor of angiogenesis, highlighting a dual regulatory role that may depend on the local balance of growth‐factor signals. In disorders as diverse as polycystic ovary syndrome, these alterations in VEGF‐B expression further support its involvement in modulating disease pathology."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "13", "end_ref": "24"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its vascular and metabolic roles, VEGF‐B also appears to exert neuroprotective and neurotrophic effects. Elevated expression in dysplastic neurons and in models of amyotrophic lateral sclerosis suggests that VEGF‐B may promote neuronal survival via autocrine and paracrine signaling mechanisms. In ocular tissues, VEGF‐B contributes to pathological neovascularization linked with diabetic retinopathy, while circulating levels have also been associated with modifications in insulin secretion dynamics—underscoring an intersection between neurovascular integrity and metabolic control. Additionally, novel peptide‐based strategies targeting the VEGF‐B/neuropilin‐1 axis are under investigation, pointing to promising therapeutic applications in neurologic and inflammatory conditions."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "25", "end_ref": "31"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Maija Bry, Riikka Kivelä, Veli-Matti Leppänen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Vascular endothelial growth factor-B in physiology and disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Physiol Rev (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/physrev.00028.2013"}], "href": "https://doi.org/10.1152/physrev.00028.2013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24987005"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24987005"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Xuri Li, Marc Tjwa, Inge Van Hove, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arterioscler Thromb Vasc Biol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/ATVBAHA.107.158725"}], "href": "https://doi.org/10.1161/ATVBAHA.107.158725"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18511699"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18511699"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "S Trompezinski, O Berthier-Vergnes, A Denis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Comparative expression of vascular endothelial growth factor family members, VEGF-B, -C and -D, by normal human keratinocytes and fibroblasts."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Dermatol (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.0906-6705.2004.00137.x"}], "href": "https://doi.org/10.1111/j.0906-6705.2004.00137.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15009103"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15009103"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Shalini Iyer, Paula I Darley, K Ravi Acharya "}, {"type": "b", "children": [{"type": "t", "text": "Structural insights into the binding of vascular endothelial growth factor-B by VEGFR-1(D2): recognition and specificity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M110.130658"}], "href": "https://doi.org/10.1074/jbc.M110.130658"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20501651"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20501651"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Shalini Iyer, Pierre D Scotney, Andrew D Nash, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Crystal structure of human vascular endothelial growth factor-B: identification of amino acids important for receptor binding."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Biol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jmb.2006.03.002"}], "href": "https://doi.org/10.1016/j.jmb.2006.03.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16616187"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16616187"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Philip Leonard, Pierre D Scotney, Talat Jabeen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Crystal structure of vascular endothelial growth factor-B in complex with a neutralising antibody Fab fragment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Biol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jmb.2008.09.076"}], "href": "https://doi.org/10.1016/j.jmb.2008.09.076"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18930733"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18930733"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Annelie Falkevall, Annika Mehlem, Isolde Palombo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reducing VEGF-B Signaling Ameliorates Renal Lipotoxicity and Protects against Diabetic Kidney Disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Metab (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cmet.2017.01.004"}], "href": "https://doi.org/10.1016/j.cmet.2017.01.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28190774"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28190774"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Terhi Karpanen, Maija Bry, Hanna M Ollila, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circ Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCRESAHA.108.178459"}], "href": "https://doi.org/10.1161/CIRCRESAHA.108.178459"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18757827"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18757827"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "C Y Sun, C C Lee, M F Hsieh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Clinical association of circulating VEGF-B levels with hyperlipidemia and target organ damage in type 2 diabetic patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Regul Homeost Agents (2014)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25001655"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25001655"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Mohammad Ishraq Zafar, Juan Zheng, Wen Kong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The role of vascular endothelial growth factor-B in metabolic homoeostasis: current evidence."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biosci Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BSR20171089"}], "href": "https://doi.org/10.1042/BSR20171089"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28798193"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28798193"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Yaping Wei, Shiyu Han, Ruonan Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased Serum VEGF-B Level Is Associated With Renal Function Impairment in Patients With Type 2 Diabetes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Endocrinol (Lausanne) (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3389/fendo.2022.862545"}], "href": "https://doi.org/10.3389/fendo.2022.862545"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35399943"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35399943"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Alireza Raissadati, Raimo Tuuminen, Alexey Dashkevich, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Vascular Endothelial Growth Factor-B Overexpressing Hearts Are Not Protected From Transplant-Associated Ischemia-Reperfusion Injury."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Clin Transplant (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.6002/ect.2016.0181"}], "href": "https://doi.org/10.6002/ect.2016.0181"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27588416"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27588416"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Amato de Paulis, Nella Prevete, Isabella Fiorentino, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression and functions of the vascular endothelial growth factors and their receptors in human basophils."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.177.10.7322"}], "href": "https://doi.org/10.4049/jimmunol.177.10.7322"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17082651"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17082651"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Kristen K Ciombor, Jordan Berlin, Emily Chan "}, {"type": "b", "children": [{"type": "t", "text": "Aflibercept."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-12-2911"}], "href": "https://doi.org/10.1158/1078-0432.CCR-12-2911"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23444216"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23444216"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Mitsuro Kanda, Shuji Nomoto, Yoko Nishikawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Correlations of the expression of vascular endothelial growth factor B and its isoforms in hepatocellular carcinoma with clinico-pathological parameters."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Surg Oncol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jso.21095"}], "href": "https://doi.org/10.1002/jso.21095"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18537151"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18537151"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "P Wang, S-H Chen, W-C Hung, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Fluid shear promotes chondrosarcoma cell invasion by activating matrix metalloproteinase 12 via IGF-2 and VEGF signaling pathways."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2014.397"}], "href": "https://doi.org/10.1038/onc.2014.397"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25435370"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25435370"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Wang-Yu Cai, Zi-Nan Dong, Xiao-Teng Fu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Theranostics (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/thno.47938"}], "href": "https://doi.org/10.7150/thno.47938"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32754268"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32754268"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Chunsik Lee, Rongyuan Chen, Guangli Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VEGF-B prevents excessive angiogenesis by inhibiting FGF2/FGFR1 pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Signal Transduct Target Ther (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41392-023-01539-9"}], "href": "https://doi.org/10.1038/s41392-023-01539-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37591843"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37591843"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Gang Liu, Shengbao Xu, Fanglei Jiao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Vascular endothelial growth factor B coordinates metastasis of non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-014-2829-5"}], "href": "https://doi.org/10.1007/s13277-014-2829-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25424698"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25424698"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Feifei Cheng, Lu Zhao, Yuanyuan Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Serum vascular endothelial growth factor B is elevated in women with polycystic ovary syndrome and can be decreased with metformin treatment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Endocrinol (Oxf) (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cen.12950"}], "href": "https://doi.org/10.1111/cen.12950"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26387747"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26387747"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Caren Jayasinghe, Nektaria Simiantonaki, Charles James Kirkpatrick "}, {"type": "b", "children": [{"type": "t", "text": "VEGF-B expression in colorectal carcinomas and its relevance for tumor progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Histol Histopathol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.14670/HH-28.647"}], "href": "https://doi.org/10.14670/HH-28.647"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23417498"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23417498"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Huan Zhang, Shanshan Hu, Jaceline Gislaine Pires Sanches, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sorcin promotes proliferation of hepatocellular carcinoma by regulating VEGFA/B via PI3K pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Physiol Biochem (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13105-024-01011-4"}], "href": "https://doi.org/10.1007/s13105-024-01011-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38536659"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38536659"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Yanpeng Ma, Wenyao Wang, Longlong Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Co-expression of VEGF-B and FLT-1 correlates with malignancy and prognosis of gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomark Med (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2217/bmm-2020-0608"}], "href": "https://doi.org/10.2217/bmm-2020-0608"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33856262"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33856262"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Yuan Huang, Zhen Zhang, Hanxing Tong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Chondroitin polymerizing factor promotes development and progression of colorectal cancer via facilitating transcription of VEGFB."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.18268"}], "href": "https://doi.org/10.1111/jcmm.18268"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38775031"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38775031"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Karin Boer, Dirk Troost, Wim G M Spliet, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cellular distribution of vascular endothelial growth factor A (VEGFA) and B (VEGFB) and VEGF receptors 1 and 2 in focal cortical dysplasia type IIB."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Neuropathol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00401-008-0354-6"}], "href": "https://doi.org/10.1007/s00401-008-0354-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18317782"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18317782"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Neil Sidell, Yue Feng, Lijuan Hao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Retinoic acid is a cofactor for translational regulation of vascular endothelial growth factor in human endometrial stromal cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Endocrinol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/me.2009-0155"}], "href": "https://doi.org/10.1210/me.2009-0155"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19910455"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19910455"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Bun-Hee Lee, Jin-Pyo Hong, Jung-A Hwang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Alterations in plasma vascular endothelial growth factor levels in patients with schizophrenia before and after treatment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Psychiatry Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.psychres.2015.04.020"}], "href": "https://doi.org/10.1016/j.psychres.2015.04.020"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25977072"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25977072"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "J Wu, H Wei, H Qu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Plasma vascular endothelial growth factor B levels are increased in patients with newly diagnosed type 2 diabetes mellitus and associated with the first phase of glucose-stimulated insulin secretion function of β-cell."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Endocrinol Invest (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s40618-017-0677-z"}], "href": "https://doi.org/10.1007/s40618-017-0677-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28523459"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28523459"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Ana Cirac, Thanos Tsaktanis, Tobias Beyer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Aryl Hydrocarbon Receptor-Dependent TGF-α/VEGF-B Ratio Correlates With Disease Subtype and Prognosis in Multiple Sclerosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurol Neuroimmunol Neuroinflamm (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1212/NXI.0000000000001043"}], "href": "https://doi.org/10.1212/NXI.0000000000001043"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34301821"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34301821"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Guang-Hong Zhang, Rui Qin, Shui-Hua Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effects of vascular endothelial growth factor B on proliferation and migration in EA.Hy926 cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol Rep (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11033-013-2917-4"}], "href": "https://doi.org/10.1007/s11033-013-2917-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24374930"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24374930"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Filipa Mota, Tamas Yelland, Jennie A Hutton, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Peptides Derived from Vascular Endothelial Growth Factor B Show Potent Binding to Neuropilin-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Chembiochem (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cbic.202100463"}], "href": "https://doi.org/10.1002/cbic.202100463"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34647407"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34647407"}]}]}]}
|
Synonyms | VRF, VEGFL |
Proteins | VEGFB_HUMAN |
NCBI Gene ID | 7423 |
API | |
Download Associations | |
Predicted Functions |
![]() |
Co-expressed Genes |
![]() |
Expression in Tissues and Cell Lines |
![]() |
VEGFB has 7,195 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 112 datasets.
Click the + buttons to view associations for VEGFB from the datasets below.
If available, associations are ranked by standardized value
Dataset | Summary | |
---|---|---|
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of VEGFB gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of VEGFB gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of VEGFB gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of VEGFB gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of VEGFB gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of VEGFB gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of VEGFB gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of VEGFB gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of VEGFB gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of VEGFB gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
CellMarker Gene-Cell Type Associations | cell types associated with VEGFB gene from the CellMarker Gene-Cell Type Associations dataset. | |
ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of VEGFB gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
ChEA Transcription Factor Targets | transcription factors binding the promoter of VEGFB gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of VEGFB gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of VEGFB gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing VEGFB protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing VEGFB protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with VEGFB protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with VEGFB protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of VEGFB gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
COSMIC Cell Line Gene Mutation Profiles | cell lines with VEGFB gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
CTD Gene-Chemical Interactions | chemicals interacting with VEGFB gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
CTD Gene-Disease Associations | diseases associated with VEGFB gene/protein from the curated CTD Gene-Disease Associations dataset. | |
DepMap CRISPR Gene Dependency | cell lines with fitness changed by VEGFB gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with VEGFB gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with VEGFB gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with VEGFB gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
DisGeNET Gene-Disease Associations | diseases associated with VEGFB gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
DisGeNET Gene-Phenotype Associations | phenotypes associated with VEGFB gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
DrugBank Drug Targets | interacting drugs for VEGFB protein from the curated DrugBank Drug Targets dataset. | |
ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at VEGFB gene from the ENCODE Histone Modification Site Profiles dataset. | |
ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of VEGFB gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
ENCODE Transcription Factor Targets | transcription factors binding the promoter of VEGFB gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing VEGFB from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
GAD Gene-Disease Associations | diseases associated with VEGFB gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
GAD High Level Gene-Disease Associations | diseases associated with VEGFB gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of VEGFB gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
GeneRIF Biological Term Annotations | biological terms co-occuring with VEGFB gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing VEGFB from the GeneSigDB Published Gene Signatures dataset. | |
GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of VEGFB gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of VEGFB gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of VEGFB gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of VEGFB gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of VEGFB gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of VEGFB gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
GlyGen Glycosylated Proteins | ligands (chemical) binding VEGFB protein from the GlyGen Glycosylated Proteins dataset. | |
GO Biological Process Annotations 2015 | biological processes involving VEGFB gene from the curated GO Biological Process Annotations 2015 dataset. | |
GO Biological Process Annotations 2023 | biological processes involving VEGFB gene from the curated GO Biological Process Annotations 2023 dataset. | |
GO Biological Process Annotations 2025 | biological processes involving VEGFB gene from the curated GO Biological Process Annotations2025 dataset. | |
GO Cellular Component Annotations 2015 | cellular components containing VEGFB protein from the curated GO Cellular Component Annotations 2015 dataset. | |
GO Cellular Component Annotations 2023 | cellular components containing VEGFB protein from the curated GO Cellular Component Annotations 2023 dataset. | |
GO Cellular Component Annotations 2025 | cellular components containing VEGFB protein from the curated GO Cellular Component Annotations 2025 dataset. | |
GO Molecular Function Annotations 2015 | molecular functions performed by VEGFB gene from the curated GO Molecular Function Annotations 2015 dataset. | |
GO Molecular Function Annotations 2023 | molecular functions performed by VEGFB gene from the curated GO Molecular Function Annotations 2023 dataset. | |
GO Molecular Function Annotations 2025 | molecular functions performed by VEGFB gene from the curated GO Molecular Function Annotations 2025 dataset. | |
GTEx Tissue Gene Expression Profiles | tissues with high or low expression of VEGFB gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of VEGFB gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of VEGFB gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of VEGFB gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of VEGFB gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of VEGFB gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
HPA Tissue Gene Expression Profiles | tissues with high or low expression of VEGFB gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
HPA Tissue Protein Expression Profiles | tissues with high or low expression of VEGFB protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of VEGFB gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
Hub Proteins Protein-Protein Interactions | interacting hub proteins for VEGFB from the curated Hub Proteins Protein-Protein Interactions dataset. | |
HuGE Navigator Gene-Phenotype Associations | phenotypes associated with VEGFB gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by VEGFB gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
InterPro Predicted Protein Domain Annotations | protein domains predicted for VEGFB protein from the InterPro Predicted Protein Domain Annotations dataset. | |
JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of VEGFB gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
KEGG Pathways | pathways involving VEGFB protein from the KEGG Pathways dataset. | |
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of VEGFB gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of VEGFB gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with VEGFB gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of VEGFB gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of VEGFB gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of VEGFB gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of VEGFB gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
LOCATE Curated Protein Localization Annotations | cellular components containing VEGFB protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain VEGFB protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by VEGFB gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of VEGFB gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of VEGFB gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by VEGFB gene mutations from the MPO Gene-Phenotype Associations dataset. | |
MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of VEGFB gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of VEGFB gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
Pathway Commons Protein-Protein Interactions | interacting proteins for VEGFB from the Pathway Commons Protein-Protein Interactions dataset. | |
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of VEGFB gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of VEGFB gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
PFOCR Pathway Figure Associations 2023 | pathways involving VEGFB protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
PFOCR Pathway Figure Associations 2024 | pathways involving VEGFB protein from the Wikipathways PFOCR 2024 dataset. | |
PID Pathways | pathways involving VEGFB protein from the PID Pathways dataset. | |
Reactome Pathways 2014 | pathways involving VEGFB protein from the Reactome Pathways dataset. | |
Reactome Pathways 2024 | pathways involving VEGFB protein from the Reactome Pathways 2024 dataset. | |
Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of VEGFB gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of VEGFB gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of VEGFB gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of VEGFB gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of VEGFB gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at VEGFB gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of VEGFB gene from the RummaGEO Drug Perturbation Signatures dataset. | |
RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of VEGFB gene from the RummaGEO Gene Perturbation Signatures dataset. | |
TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of VEGFB gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of VEGFB gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of VEGFB gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of VEGFB protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of VEGFB protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of VEGFB protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of VEGFB protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with VEGFB protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with VEGFB protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
WikiPathways Pathways 2014 | pathways involving VEGFB protein from the Wikipathways Pathways 2014 dataset. | |
WikiPathways Pathways 2024 | pathways involving VEGFB protein from the WikiPathways Pathways 2024 dataset. | |